Art

J-GLOBAL ID：201902271179881551   Reference number：19A0713849

Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report

免疫チェックポイント阻害剤(ニボルマブ)関連腎臓損傷と急性尿細管間質性腎炎を引き起こすために知られた付随する薬物の認識の重要性:症例報告【JST・京大機械翻訳】

Author (8)： Koda Ryo (Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Watanabe Hirofumi (Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Tsuchida Masafumi (Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Iino Noriaki (Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Suzuki Kazuo (Department of Respiratory Medicine, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Hasegawa Go (Department of Pathology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan) ,  Imai Naofumi (Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) ,  Narita Ichiei (Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
Material： BMC Nephrology (Web)
Volume： 19  Issue： 1  Page： 48  Publication year： 2018 
JST Material Number： U7437A  ISSN： 1471-2369  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Acute tubulointerstitial nephr...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0713849&from=J-GLOBAL&jstjournalNo=U7437A") }}

Thesaurus term： adrenocortical hormone ,  man ,  pathophysiology ,  non-small cell lung cancer ,  antibody ,  *case report ,  safety ,  therapy ,  administration(biology) ,  *human(primates) ,  steroid ,  diene ,  glucocorticoid ,  enone ,  alicyclic alcohol ,  alicyclic ketone ,  diketone ,  hydroxy ketone ,  polyol ,  lactam ,  ether ,  sulfoxide ,  nitrogen heterocyclic compound ,  organofluorine compound ,  polynuclear aromatic compound
Semi thesaurus term： 有害事象 ,  プログラム細胞死1受容体 ,  *急性尿細管間質性腎炎 , 【Automatic Indexing@JST】

Author keywords (6)： Acute tubulointerstitial nephritis ,  Drug-induced lymphocyte stimulating test ,  Immune checkpoint inhibitor ,  Lansoprazole ,  Nivolumab ,  Proton pump inhibitor

JST classification (1)： Urogenital diseases  (GM03000L)

Substance index (3)： Methylprednisolone ,  Creatinine ,  Lansoprazole

Reference (23)：

• N Engl J Med; Pembrolizumab for the treatment of non-small-cell lung cancer; EB Garon, NA Rizvi, R Hui; 372; 2015; 2018-2028; 10.1056/NEJMoa1501824; citation_id=CR1
• Am J Nephrol; Adverse renal effects of immune checkpoint inhibitors: a narrative review; R Wanchoo, S Karam, NN Uppal; 45; 2017; 160-169; 10.1159/000455014; citation_id=CR2
• JAMA Oncol; Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review; CF Friedman, TA Proverbs-Singh, MA Postow; 2; 2016; 1346-1353; 10.1001/jamaoncol.2016.1051; citation_id=CR3
• Nephrol Dial Transplant; Renal effects of immune checkpoint inhibitors; H Izzedine, C Mateus, C Boutros; 32; 2017; 936-942; 10.1093/ndt/gfw467; citation_id=CR4
• Kidney Int; Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors; FB Cortazar, KA Marrone, ML Troxell; 90; 2016; 638-647; 10.1016/j.kint.2016.04.008; citation_id=CR5

Terms in the title (8)： 免疫チェックポイント阻害剤 ,  ニボルマブ ,  腎臓 ,  損傷 ,  急性尿細管間質性腎炎 ,  薬物 ,  重要性 ,  症例報告